India to Australia: Propranolol Export Trade Route

The India to Australia Propranolol corridor is one of India's established pharmaceutical export routes, with 43 shipments documented worth a combined $25.5M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's propranolol manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $593.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with propranolol's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 25.1%, placing it at rank #15 among India's top propranolol export destinations globally.

On the import side, key buyers of Indian propranolol in Australia include NA, APOTEX PTY LTD , APOTEX PTY LTD and 4 others. NA is the single largest importer with 21 shipments valued at $24.5M USD.

India's propranolol exports to Australia are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , SYNERGY TRADING — together account for 100% of total trade value on this route. The average shipment value of $593.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines apo-propranolol 10mg tablets (propranolol hydrochloride tablets 10mg) (1x100s) (85932x1x100s pack ) and apo-propranolol 40mg tablets(propranololhydrochloride tablets 40mg)(65172x1x100s pack=6517200 tablets), suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 21 shipments worth $24.5M USD — representing 96% of all propranolol imports from India on this route. A total of 7 buyers are active on this corridor.